ConductScience.org, home
A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9
API referenceFor AI assistants

Trial · NCT05723835

Participant flow64

How many started, completed or left each group, period by period.

1 to 20 of 64

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Main Trial Period: Weeks 0 to 26STARTEDSGA_somapacitan (GH Treatment Naïve)4
Main Trial Period: Weeks 0 to 26STARTEDSGA_somapacitan (Previously Treated With GH)8
Main Trial Period: Weeks 0 to 26STARTEDTS_somapacitan (GH Treatment Naïve)3
Main Trial Period: Weeks 0 to 26STARTEDTS_somapacitan (Previously Treated With GH)8
Main Trial Period: Weeks 0 to 26STARTEDNS_somapacitan (GH Treatment Naïve)6
Main Trial Period: Weeks 0 to 26STARTEDNS_somapacitan (Previously Treated With GH)7
Main Trial Period: Weeks 0 to 26STARTEDISS_somapacitan (GH Treatment Naïve)2
Main Trial Period: Weeks 0 to 26STARTEDISS_somapacitan (Previously Treated With GH)9
Main Trial Period: Weeks 0 to 26Full Analysis Set (FAS)SGA_somapacitan (GH Treatment Naïve)4
Main Trial Period: Weeks 0 to 26Full Analysis Set (FAS)SGA_somapacitan (Previously Treated With GH)8
Main Trial Period: Weeks 0 to 26Full Analysis Set (FAS)TS_somapacitan (GH Treatment Naïve)3
Main Trial Period: Weeks 0 to 26Full Analysis Set (FAS)TS_somapacitan (Previously Treated With GH)8
Main Trial Period: Weeks 0 to 26Full Analysis Set (FAS)NS_somapacitan (GH Treatment Naïve)6
Main Trial Period: Weeks 0 to 26Full Analysis Set (FAS)NS_somapacitan (Previously Treated With GH)7
Main Trial Period: Weeks 0 to 26Full Analysis Set (FAS)ISS_somapacitan (GH Treatment Naïve)2
Main Trial Period: Weeks 0 to 26Full Analysis Set (FAS)ISS_somapacitan (Previously Treated With GH)9
Main Trial Period: Weeks 0 to 26Safety Analysis Set (SAS)SGA_somapacitan (GH Treatment Naïve)4
Main Trial Period: Weeks 0 to 26Safety Analysis Set (SAS)SGA_somapacitan (Previously Treated With GH)8
Main Trial Period: Weeks 0 to 26Safety Analysis Set (SAS)TS_somapacitan (GH Treatment Naïve)3
Main Trial Period: Weeks 0 to 26Safety Analysis Set (SAS)TS_somapacitan (Previously Treated With GH)8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05723835/flow

API referenceFor AI assistants